RadNet: Imaging And AI Keep The Bull Case Intact

RDNT's advanced imaging mix is expanding. I think this will continue to support its improving revenue quality and margins. RDNT's joint ventures across healthcare systems also help it deepen its integration across customers' workflows. DeepHealth is RDNT's second growth leg, as it pairs external software sales with internal workflow efficiencies.

Seeking Alpha • Aug 12, 2026

RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance Raised

RadNet tops Q2 estimates as advanced imaging and Digital Health growth accelerate, prompting a higher 2026 Imaging Center outlook.

Zacks Investment Research • Aug 11, 2026

RadNet Q2 Earnings Call Highlights

RadNet NASDAQ: RDNT reported record quarterly revenue and adjusted EBITDA for the second quarter of 2026, supported by higher imaging volumes, acquisitions, a shift toward advanced imaging procedures and growth in its Digital Health segment.

MarketBeat • Aug 10, 2026

RadNet, Inc. (RDNT) Q2 2026 Earnings Call Transcript

RadNet, Inc. (RDNT) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 10, 2026

RadNet (RDNT) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for RadNet (RDNT) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research • Aug 10, 2026

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges

Total Company Revenue increased 25.0% to a quarterly record of $622.7 million in the second quarter of 2026 from $498.2 million in the second quarter of 2025 Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 56.5% to a quarterly record of $32.4 million in the second quarter of 2026 from $20.7 million in the second quarter of 2025; Annual Recurring Revenue ( 4) (ARR) increased from $53.5 million at June 30, 2025 to $105.5 million at June 30, 2026 and sequentially increased from $96.9 million at March 31, 2026 Total Company Adjusted EBITDA ( 1) was a quarterly record of $99.7 million in the second quarter of 2026 as compared with $81.2 million in the second quarter of 2025, an increase of 22.7%; Digital Health reportable segment Adjusted EBITDA ( 1) was $2.5 million in the second quarter of 2026 compared with $3.4 million in the second quarter of 2025, the result of continued infrastructure investments to fuel growth Imaging Center Segment Adjusted EBITDA ( 1) margin increased by 17 basis points to 16.1% in the second quarter of 2026 from 16.0% in the second quarter of 2025 Adjusting for unusual or one-time items, Adjusted Earnings ( 3) was $23.2 million and Adjusted Earnings Per Share ( 3) was $0.29 for the second quarter of 2026 as compared with Adjusted Earnings ( 3) of $25.7 million and Adjusted Earnings Per Share ( 3) of $0.34 for the second quarter of 2025   As a percentage of total procedural volumes, advanced imaging increased by 238 basis points to 29.9% in the second quarter of 2026 from 27.5% in the second quarter of 2025 In the second quarter of 2026, aggregate advanced imaging (MRI, CT and PET/CT) procedural volumes increased 21.2% and same-center advanced imaging procedural volumes increased 9.6% as compared with the second quarter of 2025 As of June 30, 2026, balance sheet cash was $726.3 million and Net Debt to Adjusted EBITDA ( 1) Ratio ( 5 ) was 1.8x RadNet revises full-year 2026 Imaging Center guidance levels with increases to Revenue, Adjusted EBITDA ( 1) and Free Cash Flow ( 2 ) and reaffirms all Digital Health guidance ranges LOS ANGELES, Aug. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet” or the “Company”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 442 owned and operated outpatient imaging centers, today reported financial results for its second quarter of 2026. Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented, “The Imaging Center and Digital Health reportable operating segments continue to demonstrate strong growth and achieve record quarterly results.

GlobeNewsWire • Aug 9, 2026

Countdown to RadNet (RDNT) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Besides Wall Street's top-and-bottom-line estimates for RadNet (RDNT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.

Zacks Investment Research • Aug 6, 2026

DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound

SOMERVILLE, Mass., July 30, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced FDA 510(k) clearance for DeepHealth Breast Ultrasound,1 an AI-powered solution that brings greater standardization, clinical accuracy and efficiency to breast ultrasound imaging.

GlobeNewsWire • Jul 30, 2026

5 Takeover Targets for the AI Revolution

Tom Yeung here with your Sunday Digest . In the 2010s, getting acquired was the ultimate startup status symbol.

InvestorPlace • Jul 26, 2026

RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call

LOS ANGELES, July 22, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital health solutions, announced today that it will host a conference call to discuss its second quarter 2026 financial results on Monday, August 10, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

GlobeNewsWire • Jul 22, 2026